Pacific Edge Signs Contract with MediNcrease Health Plan in US
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB), has entered into an agreement with MediNcrease Health Plans, LLC, a national provider network in the United States, to make Cxbladder available to 5.5 million covered lives through its clients and payers. [read more]
Pacific Edge Signs First Commercial Agreement in Singapore
Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has reached a commercial agreement with Raffles Diagnostica Pte Ltd to offer its suite of Cxbladder tests in Singapore. [read more]
We welcome press and media enquiries. For further assistance, please feel free to contact us.